Polycystic ovary syndrome (PCOS) is the most frequently occurring endocrine disorder in women during reproductive age, which is associated with hyperinsulinaemia, hyperandrogenaemia and aberrant adipokines production from the adipose tissue. 1 PCOS is also a hormonal, metabolic and psychosocial disorder that severely impairs the patients' quality of life. 2 The incidence of PCOS is 6%-10% according to the National Institute of Health criteria, which reaches 15% based on the broader Rotterdam criteria. 3
PCOS is characterised by increasing ovarian stroma and antral follicles, in addition to ovarian cortical thickening and theca cell hyperplasia. 4 Women with PCOS are highly vulnerable to anovulation and infertility, and even such risk factors (obesity, abnormal uterine bleeding and diabetes) contributing to the development of endometrial cancer. 5 Multiple studies have provided evidence for the role of molecular targets in the treatment of PCOS, which include long noncoding RNAs (lncRNAs), microRNAs (miRNAs) and corresponding target genes. [6] [7] [8] LncRNA profiles in granulosa cells from patients with PCOS and healthy women demonstrate that dysregulated lncRNAs may play significant roles in steroidogenesis and granulosa cell proliferation, shedding lights on the aetiology of PCOS. 9 LncRNAs have emerged as important epigenetic mediators with critical functions in the development and disease. [10] [11] [12] HOTAIR is a 2158 bp lncRNA localised to a boundary in the HOXC gene cluster. 13 HOTAIR is highly expressed in primary breast tumours and the metastases, and the HOTAIR expression in primary tumours has been revealed to be a critical predictor of metastasis and death. 14 
For example,
HOTAIR expression is associated with the metastasis of epithelial ovarian cancer and could serve as a prognostic biomarker and potential therapeutic target in epithelial ovarian cancer. 15 In this study, we found that HOTAIR up-regulated the expression of insulin-like growth factor 1 (IGF1) via competitive binding to mi-croRNA-130a (miR-130a). A study has pointed out that miR-130a expression was associated with MDR1/P-glycoprotein-mediated drug resistance in the ovarian cancer cells. 16 IGF1 is a polypeptide hormone with high structural similarity to human pro-insulin, and thus alterations of IGF1 activity has been proposed as an option in the treatment of endocrine disorders. 17 Higher serum levels of IGF1 in PCOS women were previously reported to be correlated to the increased vascularity, which leads to the increased blood flow. 18 Accordingly, we hypothesised that the expression of HOTAIR and miR-130a might associate with the development of PCOS and their effects were exerted through regulating the expression of IGF1 in ovarian granulosa cells.
| MATERIAL S AND ME THODS

| Experimental animals
Totally, 90 Sprague Dawley (SD) rats (aged 21 d) were purchased from Beijing Vital River Laboratory Animal Technology Co., Ltd.
Before being used in the experiments, the rats were allowed to adapt to the environment for 2 d. These rats were kept under controlled environmental conditions (22-26°C; 12 hours light/dark cycle) with free access to food and water. The rats aged 23 day were classified into the normal group (n = 10) and PCOS group (n = 80). After model establishment, 10 PCOS rats were used to identify the modelling.
After successful modelling, the rest 70 rat models of PCOS were assigned into 7 groups with 10 in each group: control group, EP group (injected with empty plasmid through the caudal vein), si-HOTAIR group (injected with siRNA plasmid against HOTAIR through the caudal vein), oe-HOTAIR group (injected with overexpression plasmid of HOTAIR through the caudal vein), negative control (NC) group (injected with NC of miR-130a through the caudal vein), miR-130a mimics group (injected with miR-130a mimics through the caudal vein) and miR-130a inhibitors group (injected with miR-130a inhibitors through the caudal vein). The empty plasmid, siRNA plasmid against HOTAIR, overexpression plasmid of HOTAIR, NC of miR-130a, miR-130a mimics and miR-130a inhibitors were purchased from Shanghai GenePharma Co., Ltd. (Pudong district, Shanghai, China). The animal experimental processes were approved by the Ethics Committee of The Third Xiangya Hospital of Central South University.
| Model establishment and identification of PCOS
From the age of 23 days, PCOS rats were subcutaneous injected with dehydroepiandrosterone (DHEA) sulphate and sodium prasterone sulphate (9 mg/100 g bodyweight) and 0.4 mL water for injection, which lasted for 20 days. Rats in the normal group were injected with 0.4 mL water for injection at the same time point every day.
At 20 days later, the rats were deprived of food for 12 hours. Then the ovaries were extracted. Through vaginal smear, the oestrous cycle was determined. Serum hormonal levels, haematoxylin-eosin (HE) staining, transmission electron microscope (TEM) and terminal deoxynucleotidyl transferase-mediated dUTP nick-end labelling (TUNEL) assay were adopted to identify the models. When the models were determined as successful, the rats of each group were treated correspondingly the next day, and the continuous injection lasted for 7 days.
| Enzyme-linked immunosorbent assay (ELISA)
Rats of all the groups were deprived of food but not water after last injection. Following blood collection from heart, the serum was isolated. ELISA was employed to determine serum levels of folliclestimulating hormone (FSH), luteinising hormone (LH), teststerone (T) and oestradiol (E 2 ) (Nanjing Jiancheng Bioengineering Institute, Nanjing, Jiangsu, China). The rats were euthanised by cervical dislocation, with both ovaries extracted. The morphology and colour of ovaries were observed. The weight was measured and recorded.
| Haematoxylin and eosin staining
One side of the ovary was prepared and fixed in 10% formaldehyde for more than 24 hours. Then the ovary was dehydrated in gradient ethanol, permeabilised by xylene and embedded in paraffin after dipping in wax. The ovary was sliced to sections with a thickness of 4 μm. Subsequently, the sections were dewaxed and hydrated, followed by HE staining. After the treatment of gradient ethanol, the stained sections were permeabilised by xylene and mounted in neutral balsam. The morphological structures of ovarian follicles were observed under a light microscope.
| Transmission electron microscope (TEM) to observe ultrastructure of ovarian follicles
One side of the ovary was prepared and fixed in 2% glutaraldehyde for 24 hours, followed by slicing into blocks (1 mm 3 ). The ovarian blocks were immersed overnight after repeated rinsing by 0.1 mol/L phosphate-buffered saline (PBS). Then the blocks were fixed in 1% osmic acid at 4°C for 2 hours, followed by washing by deionised water for three times (5 min per wash). At 4°C, the ovarian blocks were dehydrated in gradient acetone and embedded, followed by polymerising at 70°C for 36 hours. Next, the blocks were sliced to semi-thin sections, which were stained by azure-methylene blue and localised under a light microscope. Then, the sections were made to ultrathin sections, treated with double electron stain of uranyl acetate-lead citrate. Under the TEM, the ultrastructures of ovarian granulosa cells, theca cells and lutein cells were observed and photographed.
| TUNEL assay
The paraffin-embedded ovarian tissues were collected for TUNEL staining. The number of apoptotic cells in the view field (×200) was calculated. Ten fields were counted and apoptotic cells in each field were recorded. The brown particles represented positive cells. The apoptotic index (AI) = (number of apoptotic cells/total cell number) × 100%.
| Separation and culture of ovarian granulosa cells
The ovarian tissues of PCOS rats were collected and immersed in normal saline immediately. Under a microscope, the capsule of ovaries and surrounding adipose tissues were removed. Normal saline was used again to rinse the erythrocytes on the surface. The ovarian tissues were placed in the serum-free DMEM/F12 medium (Gibco, Grand Island, NY, USA), where the follicles were pierced to release ovarian granulosa cells. Then, the ovarian granulosa cells were gently triturated to suspend single cells, which were filtered by a 200 mesh screen and centrifuged at 1000 rpm for 8 minutes with supernatant discarded and cells harvested. The deposited ovarian granulosa cells were added with DMEM/F12 medium supplemented with 15% foetal bovine serum (FBS) (Gibco, Grand Island) for incubation in a 5% CO 2 incubator at 37°C. The medium was replaced 24 hours later when the cells adhered to the wall. After the adhered cells were removed, the mixture was further incubated. When the cell confluence reached 80%, the cells were detached, and the cells were harvested after centrifugation. The deposited granulosa cells were added with DMEM/F12 medium and triturated to prepare cell suspension, which were stained by trypan blue. The cells were counted under the microscope and then subcultured.
| Cell grouping and treatment
The ovarian granulosa cells at logarithmic growth phase were grouped as follows: blank group (without any treatment), EP 
| Dual-luciferase reporter gene assay
The binding sites of lncRNA HOTAIR and miR-130a were pre- The experiment was conducted for three times.
The bioinformatics website (http://www.targe tscan.org) was searched to predict the targeting relationship between miR-130a and IGF1 as well as the binding sites of miR-130a and IGF1 mRNA 3'UTR. The IGF1 mRNA 3'UTR promoter region sequence containing miR-130a binding sites were synthesised, and After washing in ice-cold lysate two times, cells were rinsed in lowsalt buffer for three times and in high-salt buffer once. Antagonist miR-130a probe was set as a NC. Trizol method was adopted to extract total RNA. The expression of lncRNA HOTAIR was determined by reverse transcription-quantitative polymerase chain reaction (RT-qPCR).
| RNA isolation and quantitation
Total RNA of tissues and cells was extracted by Trizol method (Invitrogen). The high quality of RNA was confirmed by ultra-violet analysis and formaldehyde gel electrophoresis. Then 1 μg RNA was collected, which was reversely transcribed by avian myeloblastosis virus (AMV) to obtain cDNA. The primers of PCR were designed and synthesised by Shanghai GenePharma Co., Ltd. (Shanghai, China) (Table 1) , with glyceraldehyde-3-phosphate dehydrogenase (GAPDH) or U6 as an internal reference. The amplification conditions were pre-denaturation (94°C) for 5 minutes, denaturation (94°C) for 40 seconds, and followed by annealing for 40 seconds at 60°C, DNA strands extension for 1 minute at 72°C, this protocol ran for 40 cycles, followed by extension for 10 minutes at 72°C. The PCR products were verified by agarose gel electrophoresis. Threshold value was manually selected at the lowest point of all the parallelly rising logarithmic amplification curves, and the threshold cycle (Ct) value of each reaction tube was obtained. The data were analysed by 2 −ΔΔCt , which represents the multiple proportions of target gene expression of the experimental group to the control group. The formula was: ΔΔCt = (ΔCt target gene − ΔCt reference gene ) experimental group − (ΔCt target gene − ΔCt reference gene ) control group . The experiment was conducted for three times with mean value calculated.
| Western blot analysis
The protein of tissues and cells were extracted, the protein concentration of which was examined according to the instructions of bicinchoninic acid (BCA) protein assay kit (Wuhan Boster Biological Technology Co., Ltd., Wuhan, Hubei, China). The extracted protein added with uploading buffer was boiled at 95°C for 10 minutes. The extracted protein was uploaded with 30 μg for each well. Next, the extracted proteins were separated by 10% polyacrylamide gel electrophoresis (Wuhan Boster Biological Technology Co., Ltd.), with electrophoresis voltage transferring from 80 to 120 V by wet transfer. Subsequently, the proteins were 
| Cell counting kit-8 (CCK-8) assay
Cells of all the groups were collected. The former medium was discarded before detection. Each well was added with freshly Gene Sequence
Abbreviations: F, forward; GAPDH, glyceraldehyde-3-phosphate dehydrogenase; IGF1, insulin like growth factor 1; miR-130a, microRNA-130a; R, reverse; RT-qPCR, reverse transcription-quantitative polymerase chain reaction.
TA B L E 1 Primer sequences for RT-qPCR
prepared pre-warmed mixture (100 μL) containing DMEM/F12 
| Flow cytometry
Cells at logarithmic growth phase were detached in trypsin. Then cells were harvested after centrifugation, with supernatant discarded. Then cells were rinsed in pre-cooled PBS at 4°C and centrifuged at 1000 rpm for 5 minutes, which was repeated two times. The cell density was adjusted to 10 6 cells/mL. Subsequently, 200 μL cells were washed by 1 mL pre-cooled PBS two times and centrifuged.
Next, the cells were resuspended in 100 μL binding buffer, with 2 μL
Annexin V-FITC (20 μg/mL) added. Then cells were allowed to stand on the ice for 15 minutes without light exposure, followed by trans- 
| RE SULTS
| Rat model of PCOS is successfully established
From the 10 days following modelling, vaginal smear of rats was examined every day. Through the observation of 10 days, the rats in the normal group maintained regular oestrous cycle; whereas the rat models of PCOS had irregular oestrous cycle without ovulation.
The serum hormonal levels of rats were measured ( Figure 1A -D).
Compared with the normal group, the serum levels of E 2 , T and LH were increased and serum levels of FSH were reduced in the PCOS group (all P < .05).
The general conditions of ovaries of rats were observed ( Figure 1E ). The rat ovaries in the normal group had red colour. In the PCOS group, the ovaries of rats were pale with increased size and saccular dilatation follicles observed on the surface. The weight of ovaries in the PCOS group was higher than that in the normal group (P < .05).
F I G U R E 1 Identification of the establishment of rat models of PCOS. Note: A, serum levels of E 2 in PCOS rat models and normal rats determined by ELISA; B, serum levels of T in PCOS rat models and normal rats determined by ELISA; C, serum levels of LH in PCOS rat models and normal rats determined by ELISA; D, serum levels of FSH in PCOS rat models and normal rats determined by ELISA; E, weight of ovaries of PCOS rat models and normal rats; F, HE staining to observe histopathological changes of ovarian tissues of PCOS rat models and normal rats (×100); G, the ultrastructures of ovaries of PCOS rat models and normal rats observed under a TEM (×10 000); **P < .01 compared with the normal group; PCOS, polycystic ovaries syndrome; ELISA, enzyme-linked immunosorbent assay; E 2 , oestradiol; T, teststerone; LH, luteinising hormone; FSH, follicle-stimulating hormone; and TEM, transmission electron microscope 
| HOTAIR is highly expressed in ovarian tissues of PCOS rat models
The expression of HOTAIR in the ovarian tissues of rats in the normal and PCOS groups was measured by using RT-qPCR. PCOS rat models showed higher expression of HOTAIR than the normal rats (P < .05) ( Figure 2A) , which was indicative of the association of HOTAIR with
PCOS.
The efficiency of interference to the HOTAIR expression in ovarian tissues was assessed by RT-qPCR. Compared with the control and EP groups, the HOTAIR expression in ovarian tissues was significantly reduced in the si-HOTAIR group and elevated in the oe-HOTAIR group (both P < .05) ( Figure 2B ), suggesting successful interference to the HOTAIR expression in PCOS rat models.
| HOTAIR accelerates endocrine disorders, ovarian injury and apoptosis of ovarian granulosa cells
In comparison to the control and EP groups, the serum levels of E 2 , T and LH were increased and serum levels of FSH were decreased in the oe-HOTAIR group, whereas the situation was reversed in the si-HOTAIR group (all P < .05) ( Figure 3A-D) .
The weight of ovary in the oe-HOTAIR group was higher and that in the si-HOTAIR group was lower than that in the control and EP groups (P < .05) ( Figure 3E ).
HE staining ( Figure 3F 
| HOTAIR inhibits proliferation and enhances apoptosis of ovarian granulosa cells
The efficiency of interference to the HOTAIR expression in ovarian Figure 4A ), suggesting successful interference to the HOTAIR expression in ovarian granulosa cells of PCOS rat models.
The effect of HOTAIR on the viability of ovarian granulosa cells was examined by CCK-8 assay ( Figure 4B ). No significant difference was found between the blank and EP groups in the viability of ovarian granulosa cells (P > .05). The viability of ovarian granulosa cells was increased in the si-HOTAIR group and inhibited in the oe-HOTAIR group, as compared with the blank and EP groups (P < .05).
The effect of HOTAIR on the apoptosis of ovarian granulosa cells was examined by flow cytometry (Figure 4C-D) . The apoptosis rate of ovarian granulosa cells was higher in the oe-HOTAIR group and lower in si-HOTAIR group than the blank and EP groups (P < .05).
These results indicated that up-regulated HOTAIR expression could suppress the proliferation and facilitate the apoptosis of ovarian granulosa cells.
| HOTAIR inhibits expression of miR-130a and promotes expression of IGF1 in ovarian tissues and granulosa cells
HOTAIR was expressed at a high level in ovarian tissues of PCOS rat models. According to the results of RT-qPCR ( Figure 5A-D 
| HOTAIR up-regulates the expression of IGF1 via competitively binding to miR-130a
Bioinformatics online software analysis demonstrated specific binding region of HOTAIR gene sequence to miR-130a In comparison with the blank and NC groups, the expression of miR-130a was increased in the miR-130a mimics group and decreased in the miR-130a inhibitors group; moreover, the mRNA and protein expression of IGF1 was decreased in the miR-130a mimics group and increased in the miR-130a inhibitors group (P < .05) ( Figure 6D-G) . Thus, we could conclude that the interference to the expression of miR-130a in the ovarian granulosa cells was successful and miR-130a negatively regulated the expression of IGF1.
Bioinformatics online software (http://www.targe tscan.
org) predicted the targeting relationship of miR-130a and IGF1
( Figure 6H ). The IGF1-3'UTR-WT plasmid and miR-130a mimics were cotransfected in the ovary granulosa cells. In the WT, the luciferase activity in the IGF1-3'UTR-WT + NC group was lower than that in the IGF1-3'UTR-WT + miR-130a mimics group (P < .05). In the MUT, the luciferase activity in the IGF1-3'UTR-MUT + NC group didn't differ from that in the IGF1-3'UTR-MUT + miR-130a mimics group (P > .05) ( Figure 6I ). The aforementioned results indicated that HOTAIR repressed the inhibitory effect of miR-130a on IGF1 and increased the expression of IGF1 by competitive binding to miR-130a.
The effect of HOTAIR on the expression of miR-130a and IGF1 in the ovarian tissues and granulosa cells. Note: A; the expression of miR-130a in the ovarian tissues of rats in the normal rats and PCOS rat models; B, the mRNA expression of IGF1 in the ovarian tissues of rats in the normal rats and PCOS rat models; C, the protein expression of IGF1 in the ovarian tissues of rats in the normal rats and PCOS rat models; D, the protein band patterns of IGF1 in the ovarian tissues of rats in the normal rats and PCOS rat models; E, the expression of miR-130a in the ovarian tissues of PCOS rat models; F, the mRNA expression of IGF1 in the ovarian tissues of PCOS rat models; G, the protein expression of IGF1 in the ovarian tissues of PCOS rat models; H, the protein band patterns of IGF1 in the ovarian tissues of PCOS rat models; I, the expression of miR-130a in the ovarian granulosa cells of PCOS rat models; J, the mRNA expression of IGF1 in the ovarian granulosa cells of PCOS rat models; K, the protein expression of IGF1 in the ovarian granulosa cells of PCOS rat models; L, the protein band patterns of IGF1 in the ovarian granulosa cells of PCOS rat models; **P < .01 compared with the normal group; *P < .05 compared with the control group or blank group; and PCOS, polycystic ovaries syndrome 
| MiR-130a attenuates endocrine disorders, ovarian injury and apoptosis of ovarian granulosa cells
The serum levels of E 2 , T and LH were not significantly different between the control group and NC group (all P > .05). Compared with the control and NC groups, serum levels of E 2 , T and LH were reduced and serum levels of FSH were elevated in the miR-130a mimics group, whereas the situation was reversed in the miR-130a inhibitors group (P < .05; Figure 7A -D).
The weight of ovary in the miR-130a mimics group was lower and that in the miR-130a inhibitors group was higher, when compared with the control and NC groups (P < .05; Figure 7E ).
Under the light microscope, in the control and NC groups, obviously cystically dilatated follicles and loosely aligned granulosa cells were observed; the layers of granulosa cells were reduced and few lutein cells could be found. In the miR-130a mimics group, cystic dilatation in ovarian follicles was reduced and layers of granulosa cells were increased. In the miR-130a inhibitors group, plenty of saccular dilatation follicles could be seen; lutein cells and follicle development of different stages in the ovaries were decreased; few dominant follicles and granulosa cells could be observed ( Figure 7F ).
The ultrastructures of ovaries were observed under a TEM ( Figure 7G ). In the control and NC groups, ovarian granulosa cells were irregularly shaped; plenty of round, oval or irregular mitochondria and vacuolated mitochondrial cristae were found in the cytoplasm. In the miR-130a inhibitors group, large numbers of round, oval or irregular mitochondria and obviously vacuolated mitochondrial cristae were observed in the ovarian granulosa cells. In the miR-130a mimics group, a number of granular endoplasmic reticulum and smooth endoplasmic reticulum could be found in the ovarian granulosa cells; the mitochondria was reduced, most of which were round or oval shaped; almost no lipid droplets and few lysosomes were observed; the nuclei were in round shape with uniform sizes.
TUNEL staining was used to evaluate the effect of miR-130a on the apoptosis of ovarian granulosa cells ( Figure 7H-I) . The AI of ovarian granulosa cells was lower in the miR-130a mimics group and higher in the miR-130a inhibitors group than the control and NC groups (P < .05).
F I G U R E 6
The identification of competitive binding of HOTAIR to miR-130a as well as bindings of miR-130a and IGF1. Note: A, the binding sites of HOTAIR to miR-130a predicted by bioinformatic online software; B, the luciferase activity detected by dual-luciferase reporter gene assay to verify the binding of HOTAIR to miR-130a; C, the binding of HOTAIR to miR-130a confirmed by RNA-pull down assay; D, the expression of miR-130a in the ovarian granulosa cells; E, the mRNA expression of IGF1 in the ovarian granulosa cells; F, the protein expression of IGF1 in the ovarian granulosa cells; G, the protein band patterns of IGF1 in the ovarian granulosa cells; H, the binding sites of miR-130a to IGF1 predicted by bioinformatic online software; I, the luciferase activity detected by dual-luciferase reporter gene assay to verify the targeting relationship of miR-130a to IGF1; *P < .05 compared with the NC group or blank group; PCOS, polycystic ovaries syndrome; NC, negative control 
| MiR-130a enhances proliferation and inhibits apoptosis of ovarian granulosa cells
The effect of miR-130a on the viability of ovarian granulosa cells was examined by CCK-8 assay ( Figure 8A ). Increased viability and proliferation rate of ovarian granulosa cells was found in the miR-130a mimics group; reduced viability and proliferation rate of ovarian granulosa cells was identified in the miR-130a inhibitors group, as compared with the blank and NC groups (P < .05).
The effect of miR-130a on the apoptosis of ovarian granulosa cells was examined by flow cytometry (Figure 8A ). The apoptosis rate of ovarian granulosa cells was lower in the miR-130a mimics group and higher in miR-130a inhibitors group than the blank and NC groups (P < .05). These results indicated that up-regulated miR-130a expression could promote the proliferation and impede the apoptosis of ovarian granulosa cells.
| D ISCUSS I ON
PCOS, as the most common cause of female infertility across the globe, is a multi-causal and genetically complicated disorder, which is implicated in the failure in endocrine glands. 19, 20 In the ovarian cancer, inhibited HOTAIR expression in ovarian cancer cells could impede the tumourgenesis and metastasis. 21, 22 According to Deng et al, HOTAIR modulates the self-renewal, growth, tumour metastatic and formation of the cancer stem-like cell subpopulation enriched from breast cancer cells. 23 Moreover, the levels of IGF1 are elevated and may affect ovarian function and increase androgen production in PCOS. 24 Herein, we identified the expression of HOTAIR, miR-130a and IGF1 in the ovarian tissues and granulosa cells of PCOS rat models and verified the regulatory relationships among them, so as to determine the mechanisms of controlling the endocrine disorders and activities of ovarian granulosa cells.
PCOS rat models were established by injection of DHEA. In the separated ovarian tissues and granulosa cells of rat models of PCOS, a high level of HOTAIR expression and IGF1 expression as well as a low level of miR-130a expression were identified. It has been proved that HOTAIR rs920778 polymorphism is associated with ovarian cancer susceptibility and prognosis in a Chinese population. 25 Then, the therapeutic value of HOTAIR in ovarian and breast cancers has been demonstrated using tumour specific peptides inhibits HOTAIR activity. 26 Silencing of HOTAIR could inhibit the tumour growth and increase chemosensitivity In this present study, we found that HOTAIR accelerated the endocrine disorders, ovarian injury and apoptosis of granulosa cells in rat models of PCOS. HOTAIR is located between HoxC11 and HoxC12 in the human genome and mediates HoxD expression in multiple tissues. 28 A study has revealed that IGF1 expression was elevated in human epithelial ovarian cancer samples in relation to that in benign ovarian tumour samples. 29 Another study also proved that IGF1 level was up-regulated in plasma of well-differentiated epithelial ovarian cancer. 30 As Zhang et al state that miR-130a expression was markedly reduced in cisplatin-resistant ovarian cancer cells. 31 Epigenetic alterations of HOX genes can be correlated with PCOS and consequently female infertility, which provide insight for novel treatments with epidrugs for this disease.
Notably, HOTAIR was validated to negatively regulate the expression of miR-130a and positively regulate the expression of IGF1 in PCOS rat models. Furthermore, we confirmed that HOTAIR repressed the inhibitory effect of miR-130a on IGF1 and increased the expression of IGF1 by competitive binding to miR-130a.
It has been suggested that miR-130 expression interacting with
Hox genes could control vascular morphogenesis in developing lung. 32 The role of miR-130a was characterised in reducing HOXA5 expression, thus decreasing p53 expression and controlling breast cancer cells resulting in tumour progression and metastasis. 33 MiR-130a attenuated endocrine disorders, ovarian injury and apoptosis of granulosa cells in rat models of PCOS. The expression of miR-130a has been examined in ovarian cancer cells, and it is involved in the cell activities and drug resistance. 16 MiR-130a may be a potential treatment target in ovarian cancers through inhibiting PTEN to activate PI3K/AKT signalling pathway. 34 According to a previous integrated gene network analysis, miR-130a expression is associated with multidrug resistance in epithelial ovarian cancer by binding to NRP1. 35 MiR-130a enhanced proliferation and inhibits apoptosis of ovarian granulosa cells in the rat models of PCOS of this study. MiR-130a directly targeted and negatively regulated the expression of IGF1. When the expression of IGF1 was reduced, women with PCOS may be more sensitive to the treatment of octreotide. 36 IGF1 might be attributed to the increase in serum levels of LH and the consequent hyperandrogenic anovulation in women with PCOS. 37, 38 The bioavailability of IGF1 has been reported to play a key role in oocyte maturation in PCOS patients. 39 By demonstrating that HOTAIR up-regulated the expression of IGF1 via competitive binding to miR-130a in the rat models of PCOS, we provide insight into the mechanisms underlying the promotion effect of up-regulated HOTAIR expression in the endocrine disorders and granulosa cell apoptosis. We show that HOTAIR up-regulates the expression of IGF1 and aggravates the endocrine disorders and granulosa cell apoptosis through competitive binding to miR-130a in rat models of PCOS. Based on our finding, we predict that competitive binding of HOTAIR to miR-130a may act as a novel target for the molecular treatment of PCOS. However, whether treatment will affect other organs and systems and whether it will directly or indirectly affect the ovaries will be explained in future study.
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